by Marco Albrecht | Mar 16, 2023 | Aktuell, Corporate
esqLABS awarded £1.6M to develop a Virtual Second Species "biggest award to date in a single investment for an exciting project through our CRACK IT Challenges innovation programme" CRACK IT Mega Challenge: Virtual Second Species: Phase II esqLABS, led by Dr Stephan...
by Stephan Schaller | Mar 15, 2023 | Aktuell, Events
Meet us at #ASCPT2023 esqLABS will present 2 posters and sponsor a networking event on March 24, 10:30 AM The American Society of Clinical Pharmacology & Therapeutics (ASCPT) Meeting in Atlanta will be reuniting scientists around the world at first in-person...
by Stephan Schaller | Mar 14, 2023 | Aktuell 2, Events
Meet us at #SOT2023 esqLABS will present 3 posters and a CE course (CEAM02) The Society of Toxicology (SOT) Meeting in Nashville, will be reuniting scientists around the world after turbulent recent years. SOT brings together 5,000+ toxicologists and those working in...
by Stephan Schaller | Mar 12, 2023 | Aktuell 2, Events
PAGE 2023: 2x 1-Day (advanced) OSP Suite Workshop & Webinar June 26 & 27th, Palexco, A Coruña, Spain EsqLABS workshop on (advanced) PBPK and QSP modelling in PK-Sim® and MoBi® Join esqLABS on June 26th and 27th for a dynamic 1 or 2-day workshop showcasing the latest...
by Marco Albrecht | Mar 7, 2023 | Aktuell, Corporate
New organ-on-chip pilot seeks to reduce animal testing in consumer health industry A pilot project, supported by esqLABS, Dynamic42, Placenta Lab of Jena University Hospital, and Bayer’s Consumer Health Division New organ-on-chip pilot Animal testing has been a major...
